journal article·2019-04-30Open access

Analysis of Sulfated Glycosaminoglycans in ECM Scaffolds for Tissue Engineering Applications: Modified Alcian Blue Method Development and Validation

Tuyajargal Iimaa, Yasuhiro Ikegami, Ronald Bual, Nana Shirakigawa, Hiroyuki Ijima

Abstract

Accurate determination of the amount of glycosaminoglycans (GAGs) in a complex mixture of extracellular matrix (ECM) is important for tissue morphogenesis and homeostasis. The aim of the present study was to investigate an accurate, simple and sensitive alcian blue (AB) method for quantifying heparin in biological samples. A method for analyzing heparin was developed and parameters such as volume, precipitation time, solvent component, and solubility time were evaluated. The AB dye and heparin samples were allowed to react at 4 ℃ for 24 h. The heparin-AB complex was dissolved in 25 N NaOH and 2-Aminoethanol (1:24 v/v). The optical density of the solution was analyzed by UV-Vis spectrometry at 620 nm. The modified AB method was validated in accordance with U.S. Food and Drug Administration guidelines. The limit of detection was found to be 2.95 µg/mL. Intraday and interday precision ranged between 2.14–4.83% and 3.16–7.02% (n = 9), respectively. Overall recovery for three concentration levels varied between 97 ± 3.5%, confirming good accuracy. In addition, this study has discovered the interdisciplinary nature of protein detection using the AB method. The basis for this investigation was that the fibrous protein inhibits heparin-AB complex whereas globular protein does not. Further, we measured the content of sulfated GAGs (sGAGs; expressed as heparin equivalent) in the ECM of decellularized porcine liver. In conclusion, the AB method may be used for the quantitative analysis of heparin in ECM scaffolds for tissue engineering applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Glycosylation and Glycoproteins Research · Tribology and Lubrication Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-Ku, Fukuoka 819-0395, Japan

Department of Biochemistry and Laboratory Medicine, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia

Department of Chemical Engineering & Technology, College of Engineering, Mindanao State University-Iligan Insititute of Technology, Iligan 9200, Philippines

References (34)

Show source-provided references
1. Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges10.1146/annurev-chembioeng-061010-114257 ↗
2. Extracellular matrix structure10.1016/j.addr.2015.11.001 ↗
3. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds10.1002/bit.10605 ↗
4. Collagen-based biomaterials as 3D scaffold for cell cultures: Applications for tissue engineering and gene therapy10.1007/BF02344779 ↗
5. Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans10.1016/0006-291X(89)91609-4 ↗
6. Decellularized liver matrix-modified cryogel scaffolds as potential hepatocyte carriers in bioartificial liver support systems and implantable liver constructs10.1021/acsami.7b13727 ↗
7. Proteoglycans: From structural compounds to signaling molecules10.1007/s00441-009-0821-y ↗
8. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2015). Proteoglycans and sulfated glycosaminoglycans. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press. [3rd ed.]. Chapter 17.
9. Roles of heparan-sulphate glycosaminoglycans in cancer10.1038/nrc842 ↗
10. Heparan sulfate proteoglycans: Structure, protein interactions and cell signaling10.1590/S0001-37652009000300007 ↗
11. Heparan sulfate and heparin interactions with proteins10.1098/rsif.2015.0589 ↗
12. Heparin-protein interactions
13. Proteoglycans in health and disease: Novel roles for proteoglycans in malignancy and their pharmacological targeting10.1111/j.1742-4658.2010.07800.x ↗
14. Quantification of glycosaminoglycans by reversed-phase HPLC separation of fluorescent isoindole derivatives10.1093/glycob/cwj037 ↗
15. Complex glycosaminoglycans: Profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy10.1016/j.ab.2004.10.012 ↗
16. Chemokine-Glycosaminoglycan Binding: Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry10.1074/jbc.M505738200 ↗
17. Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone–labeled disaccharides with LC-fluorescence and LC-MS detection10.1038/nprot.2014.026 ↗
18. Isolation and characterization by electrospray-ionization mass spectrometry and high-performance anion-exchange chromatography of oligosaccharides derived from hyaluronic acid by hyaluronate lyase digestion: Observation of some heretofore unobserved oligo10.1016/S0008-6215(97)00171-7 ↗
19. Quantification of hyaluronan in pharmaceutical formulations using high performance capillary electrophoresis and the modified uronic acid carbazole reaction10.1016/S0731-7085(99)00120-X ↗
20. Differential Use of Alcian Blue and Toluidine Blue Dyes for the Quantification and Isolation of Anionic Glycoconjugates from Cell Cultures: Application to Proteoglycans and a High-Molecular-Weight Glycoprotein Synthesized by Articular Chondrocytes10.1006/abio.2000.4761 ↗
21. Characterization of the interaction between methylene blue and glycosaminoglycans10.1016/S1386-1425(98)00323-0 ↗
22. Fractional determination of sodium chondroitin sulfate/hydroxypropylmethyl cellulose mixture using Alucian Blue 8GX10.2116/bunsekikagaku.52.259 ↗
23. The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods10.2174/1875398100801010031 ↗
24. The chemical and histochemical properties of Alcian Blue—I. The mechanism of Alcian Blue staining10.1007/BF00306149 ↗
25. Rapid and sensitive anthrone e sulfuric acid assay in microplate format to quantify carbohydrate in biopharmaceutical products: Method development and validation10.1016/j.biologicals.2007.09.001 ↗
26. U.S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM) (2019, April 30). Guidance for Industry. Bioanalytical Method Validation, Available online: http://www.labcompliance.de/documents/FDA/FDA-Others/Laboratory/f-507-bioanalytical-4252fnl.pdf.
27. Analytical & Bioanalytical techniques UV-visible spectrophotometric method development and validation of assay of paracetamol tablet formulation10.4172/2155-9872.1000151 ↗
28. Ich (2005). ICH Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology.
29. Methods for the determination of limit of detection and limit of quantitation of the analytical methods
30. Quantitation of proteoglycans in biological fluids using Alcian blue
31. The specificity of interactions between proteins and sulfated polysaccharides10.1590/S0001-37652005000400007 ↗
32. Elastic proteins: Biological roles and mechanical properties10.1098/rstb.2001.1022 ↗
33. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils10.1016/j.jsb.2008.07.001 ↗
34. Heparin–protein interactions: From affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis10.1016/j.matbio.2013.11.001 ↗